Filing Details
- Accession Number:
- 0001225208-13-003595
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-11 16:08:33
- Reporting Period:
- 2013-02-08
- Filing Date:
- 2013-02-11
- Accepted Time:
- 2013-02-11 16:08:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202294 | Elliot Sigal | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp, Cso & President R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2013-02-08 | 147,749 | $17.51 | 195,801 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2013-02-08 | 70,000 | $22.73 | 265,801 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2013-02-08 | 48,333 | $28.11 | 314,134 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2013-02-08 | 224,705 | $36.79 | 89,429 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-02-08 | 147,749 | $0.00 | 147,749 | $17.51 |
Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-02-08 | 70,000 | $0.00 | 70,000 | $22.73 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2013-02-08 | 48,333 | $0.00 | 48,333 | $28.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-03-02 | No | 4 | M | Direct | |
25,795 | 2016-03-06 | No | 4 | M | Direct | |
0 | 2014-03-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 1,616 | Indirect | By BMY Savings & Investment Program |
Common Stock, $0.10 Par Value | 37,412 | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
Common Stock, $0.10 Par Value | 37,412 | Indirect | By Ruth L. Sigal Irrevocable Trust |
Common Stock, $0.10 Par Value | 18,707 | Indirect | By Sigal Family Investments, LLC |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.73 to $36.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004.